Document |
Document Title |
WO/1999/062871A1 |
Novel 3-aryl proprionic acid derivatives and analogs, having general formula (I) and stereo- and optical isomers and racemates thereof as well as pharmaceutically acceptable salts, solvates and crystalline forms thereof, process for thei...
|
WO1999051546A9 |
The present invention provides methods and compositions, i.e. synthetic libraries of candidate compounds, useful in the discovery and optimization of compounds which catalyze at least one chemical transformation. In certain instances, th...
|
WO/1999/051570A1 |
Disclosed is an anion-complexing compound (I) wherein R1 and A represent an aromatic 6-ring, Y' represents a -NHC(X)NH-group, and Y' represents a rest selected from the group -NHC(X')-, -C(X')NH- and -NHC(X')NH-, wherein X and X', indepe...
|
WO/1999/036393A1 |
The present invention relates to a pharmaceutical composition comprising as an active ingredient a compound of formula (I), wherein Ring A is an aromatic or a heterocyclic ring; Q is a bond, carbonyl, lower alkylene, lower alkenylene, -O...
|
WO/1999/033790A1 |
Fluoro-substituted benzoylureas of formula (I) wherein R?1¿, R?2¿ and R?3¿ each independently represent a hydrogen atom, nitro, cyano, halogen, C¿1-3?-alkyl, C¿1-3?-haloalkyl, C¿1-3?-alkoxy, C¿1-3?-haloalkoxy, C¿1-3?-alkylthio or...
|
WO/1999/032463A1 |
This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases, and pharmaceutical compositions for use in such therapy.
|
WO/1999/032433A1 |
The present invention provides compounds of formula (I). The present invention also provides methods of treating or preventing inflammation or atherosclerosis, and a pharmaceutical composition that contains a compound of formula (I).
|
WO/1999/029655A1 |
The invention relates to compounds of formula (I), wherein R?1¿ and R?2¿, independently from each other, mean hydrogen, halogen or C¿1-4? alkyl group; R?3¿, R?4¿ and R?5¿, independently from each other, stand for hydrogen or C¿1-4...
|
WO/1999/028984A1 |
The invention concerns novel electrode materials derived from polyquinoid ionic compounds and their uses such as in electrochemical generators. It concerns in particular compounds such as a rhodizonic acid salt; a rufigallic acid salt; a...
|
WO/1999/010313A1 |
Compounds of formula (I) are disclosed which have activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and /or damage are related to the binding of VC...
|
WO/1999/008992A1 |
Enantiomerically substantially pure compounds of formula (I) where R is H or lower alkyl of 1 to 6 carbons, or pharmaceutically acceptable salts thereof have retinoid-like biological activity. The enantiomerically pure or substantially p...
|
WO/1999/007672A1 |
Substituted anilines of general formula (I) wherein R?1¿, R?2¿, R?3¿, R?4¿ and X are defined in the description, compositions thereof and methods for preparing the compounds are described. The compounds are useful for the treatment o...
|
WO/1998/053688A1 |
The invention relates to a fungicidal mixture containing a synergistically effective amount of a.1) a phenyl-benzyl ether derivative of formula (I.a), (I.b) or (I.c) or a.1) a carbamate of formula (I.d), wherein X = CH and N, n = 0, 1 or...
|
WO/1998/052552A1 |
Disclosed are processes for the preparation of compounds of the formula (I): H�2?N-(CH�2?)�n?-A-(CH�2?)�m?-NH�2?, or (II): H�2?N-(CH�2?)�n?-NH-C(=NR?1�)-NH-(CH�2?)�m?-NHï¿
½2?, wherein n and m are each independent...
|
WO/1998/049152A1 |
Compounds of formula (I), wherein R?l� is an aromatic or a heteroaromatic ring; R?2� and R?3� are H, C�1?-C�8?alkyl, aryl, arylC�1?-C�8?alkyl, or heteroaryl; R?4� is an aromatic or a heteroaromatic ring or an amine; W, X,...
|
WO/1998/047879A1 |
A compound having formula (I) or a pharmaceutically acceptable salt thereof wherein one of R?1�, R?2� and R?3� is a cyclic or heterocyclic acidic functional group having a pKa value below 8 or a group which is convertible in vivo t...
|
WO/1998/046551A1 |
The invention provides methods for making a new type of library of compounds, referred to herein as a 'biased array'. The biased array is based on the premise that by preparing compounds that include (i) a common molecular core that is t...
|
WO/1998/046559A1 |
The invention is based on new methods for making and using compounds and arrays of novel $g(a)-ketoamides, and the arrays and compounds made by these methods. These novel compounds are potential inhibitors of proteolytic enzymes, particu...
|
WO/1998/045259A2 |
The present invention relates to polyaromatic compounds having useful antiviral activity against viruses of the herpes family, to a composition containing them, and to a method of using them for the treatment of herpes viruses infections.
|
WO/1998/038180A1 |
There are described processes for the preparation of a compound of formula (I), and novel intermediates in the preparative process.
|
WO/1998/031665A1 |
N-phenylthiourea derivatives useful as fungicides for agricultural and horticultural use which exhibit excellent activities particularly even at low concentrations. The derivatives are represented by general formula (I) with compounds re...
|
WO/1998/024760A1 |
The present invention provides a library of compounds, each comprised of a common animobenzenedicarboxylic acid core structure (scaffold) that serves as a template for synthesizing approximately 10?1�-10?6� compounds which are analog...
|
WO/1998/013036A1 |
S-alkylisothiouronium salts with phosphorus containing acids, including several new such compounds which are for use as medicaments for increasing arterial blood pressure or for protecting against hyperoxia. These compounds can be used f...
|
WO/1998/006262A1 |
This invention relates to the use of compounds of formula (I) in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8). The variables of (I) are defined herein.
|
WO/1998/004521A1 |
Compounds of general formula (I) wherein R?1� is H, alkyl or is selected from the group consisting of an optionally substituted aryl, an optionally substituted heteroaryl, an optionally substituted heterocyclyl and an optionally substi...
|
WO/1997/049680A1 |
This invention relates to the use of phenyl ureas of formulas (I) and (II) in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8). The variables of (I) and (II) are defined herein.
|
WO/1997/045400A1 |
The present patent application relates to compounds having formula (I) or a pharmaceutically acceptable salt thereof wherein one of R1, R2 and R3 is a non-cyclic acidic group having a pKa value below 8 or a group which is in vivo convert...
|
WO/1997/045111A1 |
The present invention relates to a method for the treatment of a disorder or disease of a living animal body, including a human, which disorder or disease is responsive to the blockade of chloride channels, comprising administering to a ...
|
WO/1997/042166A1 |
Novel amidine derivatives of general formula (1); and drug carriers (such as liposomes or emulsions) comprising the derivatives, which can enclose genetic materials or drugs and transfer them to cells or affected sites efficiently and sa...
|
WO/1997/041846A1 |
The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.
|
WO/1997/036862A1 |
The present invention relates to a class of compounds represented by Formula (I), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula (I), and methods of selectively inhibiting o...
|
WO/1997/029743A1 |
This invention relates to novel compounds and a novel use of phenyl ureas in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
|
WO/1997/023508A1 |
Compounds of peptide mimetic nature having general formula (I), wherein a and b are independently 1 or 2, R1 and R2 are independently H or C1-6alkyl, G and J are independently, inter alia, aromats, and D and E are independently several d...
|
WO/1997/009297A2 |
Aryl-substituted and aryl and (3-oxo-1-propenyl)-substituted benzopyran, benzothiopyran, 1,2-dihydroquinoline, and 5,6-dihydronaphthalene derivatives have retinoid negative hormone and/or antagonist-like biological activities. The invent...
|
WO/1997/009306A1 |
Isothiourea derivatives represented by general formula (I) or pharmacologically acceptable salts thereof, wherein R1, R2 and R3 independently represent each hydrogen, halogeno, nitro, lower alkyl or lower alkoxy; R4 and R5 independently ...
|
WO/1997/008145A1 |
The present invention relates to a class of compounds represented by formula (I) or a pharmaceutically acceptable salt thereof, wherein A is (a) or (b) or (c) or (d) pharmaceutical compositions thereof and methods of using such compounds...
|
WO/1997/002255A1 |
Bis-oxime derivatives of formula (I) in which A is (a) or (b), where W is oxygen or sulfur, and the other substituents defined as follows: R1 = hydrogen, C1-C4alkyl; cyclopropyl; R2 = hydrogen, C1-C6alkyl; halo(C1-C6) alkyl; C2-C6alkoxya...
|
WO/1996/040743A2 |
Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating coagulation disorders.
|
WO/1996/040641A1 |
There are disclosed novel substituted naphthyl-, quinolyl- and isoquinolyl- sulfonamide derivatives that are useful in a method of treating immuno-inflammatory diseases in a mammalian patient suffering therefrom. Pharmaceutical compositi...
|
WO/1996/039374A1 |
Compounds of Formula (1), wherein Z is selected from the group consisting of the radicals shown in Formula (2) and in Formula (3), Y is cycloalkyl or cycloalkenyl of 3 to 8 carbons optionally substituted with one or two R4 groups, or Y i...
|
WO/1996/033164A1 |
Hydroximic acid derivatives of general formula (I), wherein G is either G1 or G2 or G3 or G4 of the formula: R5OC=C(COOR4)-, R5ON=C(COOR4)-, R5ON=C(CONR6R7)-, R5OC=C(CONR6R7)-, X1, X2, X3 are H, halo, HO, mercapto, nitro, SCN, azido, CN,...
|
WO/1996/030329A1 |
The invention relates to substituted benzenes and derivatives thereof, useful as neuraminidase inhibitors, to pharmaceutical compositions comprising such compounds, and to methods of using these compounds for treating viral and other inf...
|
WO/1996/025157A1 |
This invention relates to the novel use of phenyl ureas in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
|
WO/1996/024580A1 |
There are disclosed novel compounds of general formula (I) which compounds of formula (I) promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the prod...
|
WO/1996/024588A1 |
There are provided novel compounds of formula (I) wherein D represents alkyl C1 to 6; T represents a C3-5 saturated or unsaturated alkylene chain substituted by -(CH2)m-NXY; -O-(CH2)2-NH- substituted by -(CH2)m-NXY; or -U-(CH2)a-N(X)-(CH...
|
WO/1996/019440A1 |
A class of acetamidine derivatives of general formula (I), methods for the manufacture thereof in therapy, particularly as inhibitors of nitric oxide synthase, is disclosed or a salt thereof, wherein R1 is hydrogen, a C1-6 hydrocarbyl gr...
|
WO/1996/018607A1 |
A compound represented by general formula (1) or possible stereoisomers and optical isomers thereof, and medicinally acceptable salts of these compounds, wherein R1 represents SR6 or NHR7; R6 represents C1-C6 alkyl, etc.; R7 represents h...
|
WO/1996/018608A1 |
A compound represented by general formula (1),zor possible stereoisomers and optical isomers thereof, and medicinally acceptable salts of these, (wherein R1 represents SR6 or NR7R8; R6 represents C1-C6 alkyl, etc.; R7 represents hydrogen...
|
WO/1996/009286A1 |
There are provided novel compounds of formula (I), wherein D, R1, R2, R3, X and p are as defined in the specification together with processes for their preparation, compositions containing them and their use in therapy. Compounds of form...
|
WO/1996/006076A1 |
A compound represented by general formula (I) or a medicinally acceptable salt thereof, (wherein R1 represents hydrogen, C1-C6 alkoxycarbonyl or C1-C9 acyl; R2 represents hydrogen or C1-C6 alkyl; R3 represents C1-C6 alkyl or C2-C6 alkeny...
|